Nivolumab plus interferon-γ in the treatment of intractable mucormycosis

David Grimaldi; Olivier Pradier; Richard S. Hotchkiss; Jean Louis Vincent

doi:10.1016/s1473-3099(16)30541-2

Related publications

Article1983

Expression of the human interferon–γ cDNA in yeast

De Clercq Erik, Arjun Singh, David V. Goeddel

Article2017

Comparison of Sofosbuvir Plus Ribavirin Treatment with Pegylated Interferon Plus Ribavirin Treatment for Chronic Hepatitis C Genotype 2

Kayo Seo, Soo Ki Kim, Soo Ryang Kim, Aya Ohtani, Mana Kobayashi, Airi Kato, Eri Morimoto, Yuka Saijo, Ke Ih Kim, Susumu Imoto, Chi Wan Kim, Yoshihiko Yano, Masatoshi Kudo, Yoshitake Hayashi

Article2004

Differential expression of interferon-γ and interferon-γ-inducing cytokines in Thai patients with scrub typhus or leptospirosis

Wirongrong Chierakul, Maaike de Fost, Yupin Suputtamongkol, R. Limpaiboon, Arjen M. Dondorp, Sir Nicholas White, Tom van der Poll

Clinical Immunology

Article2024

Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab

Helen Gogas, Shruthi Ravimohan, Antara Datta, Aparna Chhibber, Eva Muñoz‐Couselo, Adi Diab, Caio Guilherme Pereira, G. Quéreux, Shahneen Sandhu, Brendan D. Curti, Nikhil I. Khushalani, Matthew H. Taylor, Gregory A. Daniels, Anna Spreafico, Tarek Meniawy, Alfons J.M. van den Eertwegh, Yongliang Sun, Yull Arriaga, Ming Zhou, Georgina V. Long, Célèste Lebbé

Article2024

Neoadjuvant nivolumab plus ipilimumab versus adjuvant nivolumab in macroscopic, resectable stage III melanoma: The phase 3 NADINA trial.

Christian U. Blank, Minke W. Lucas, Richard A. Scolyer, Bart A. van de Wiel, Alexander M. Menzies, Marta López‐Yurda, Alexander Christopher Jonathan Van Akkooi, Winan J. van Houdt, Robyn P.M. Saw, Alex Torres Acosta, Serigne Lo, Geke A.P. Hospers, Matteo S. Carlino, Jan Willem de Groot, Ellen Kapiteijn, Karijn P.M. Suijkerbuijk, Piotr Rutkowski, Shahneen Sandhu, Astrid Aplonia Maria Van Der Veldt, Georgina V. Long